Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized budesonide and spirometric indices in COPD exacerbation
IRCT20170808035565N3Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Sep 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of budesonide in chronic obstructive pulmonary disease (COPD), sponsored by Mazandaran University of Medical Sciences. Started Sep 2018; status: completed.
02
Drugs
budesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT20170808035565N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170808035565N3.